---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-061148"
form_type: "8-K"
ticker: "CAI"
cik: "0002019410"
company_name: "Caris Life Sciences, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:03:19.948946+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Caris Life Sciences completes IPO of 23.5M shares at $21.00, raising $494.1M gross

## Summary
- IPO of 23,529,412 shares of common stock at $21.00 per share closed June 20, 2025.
- Gross proceeds of $494.1 million before underwriting discounts and estimated offering expenses.
- Amended and restated certificate of formation and bylaws became effective upon IPO closing.
- Shares trade on Nasdaq under ticker CAI.

## SEC filing metadata
- accession: 0001104659-25-061148
- form_type: 8-K
- ticker: CAI
- cik: 0002019410
- company_name: Caris Life Sciences, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/tm2518546d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-061148
- JSON: https://secwatch.observer/filing/0001104659-25-061148.json
- Plain text: https://secwatch.observer/filing/0001104659-25-061148.txt

## Key facts
- Governance Changes
  Caris Life Sciences, Inc.: Amended and Restated Certificate of Formation effective upon closing of IPO (effective 2025-06-20).
  - Change: charter amendment
  - Effective: 2025-06-20
  source text: On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm
- Governance Changes
  Caris Life Sciences, Inc.: Amended and Restated Bylaws effective upon closing of IPO (effective 2025-06-20).
  - Change: bylaw amendment
  - Effective: 2025-06-20
  source text: On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.